15:12 | First To File : Issue 9 |  |
15:05 | MassBio - Pfizer Pharma Day to ignite breakthrough partnerships |  |
14:52 | Cronache di Borsa - Mercoledì 1 Febbraio |  |
11:09 | GSK: bénéfice 2022 dopé par la scission des soins grand public |  |
08:44 | Morning Briefing - Markt Schweiz |  |
08:27 | Novartis présente la candidature d'un ancien de Pfizer pour son conseil |  |
07:24 | Novartis schlägt früheren Pfizer-Manager für den Verwaltungsrat vor |  |
07:13 | Wall Street : clôture en nette hausse dans l'attente du FOMC |  |
05:59 | China mRNA vaccine development jumps into high gear |  |
03:54 | Simcere Starts Marketing Oral COVID-19 Drug at 40% Less Than Price of Pfizer’s Pa.. |  |
31/01 | Factbox-What ending the U.S. COVID health emergency means for your pocket |  |
31/01 | Health Care Edges Higher After Mixed Pfizer Earnings -- Health Care Roundup |  |
31/01 | Aktien New York Schluss: Dow und S&P 500 machen Vortagsverluste .. |  |
31/01 | Ganancias destacadas en un Wall Street que descuenta resultados |  |
31/01 | MÄRKTE USA/Fester - US-Notenbank und Berichtssaison im Fokus |  |
31/01 | Aktien New York: Deutliche Erholung vor Fed-Zinsentscheid und nach Zahle.. |  |
31/01 | Bourses: l'Europe prudente, Wall Street positive |  |
31/01 | Point marchés-L'Europe finit dans le désordre, attentisme sur les banques centrales |  |
31/01 | Drugmaker Pfizer starts low with 2023 earnings forecast |  |
31/01 | MÄRKTE USA/Etwas fester - US-Notenbank und Berichtssaison im Fokus |  |
31/01 | Global markets live: GM, Pfizer, Exxon, UBS, Boeing... |  |
31/01 | Wall Street : amorce de rebond à la veille de la Fed |  |
31/01 | CAC40 : finit 1 mois de janvier record sans perdre de terrain |  |
31/01 | Pfizer prevede forte calo vendite prodotti Covid in 2023 |  |
31/01 | La prudence se confirme sur les marchés boursiers avant les banques centrales |  |
31/01 | CAC40 : gain de +9,4% en janvier, beaucoup de stats en Europe |  |
31/01 | Wall Street ouvre en hausse, la hausse des salaires ralentit |  |
31/01 | Rückenwind durch Corona-Pandemie lässt bei Pfizer nach |  |
31/01 | MÄRKTE USA/Wall Street zum Start leicht im Plus |  |
31/01 | Pfizer prevede forte calo vendite prodotti Covid in 2023 |  |
31/01 | Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn |  |
31/01 | Dpa-AFX-Überblick: UNTERNEHMEN vom 31.01.2023 - 15.15 Uhr |  |
31/01 | Wall Street : les résultats peinent toujours à convaincre |  |
31/01 | Les valeurs à suivre aujourd'hui à Wall Street - Mardi 31 janvier 2023 |  |
31/01 | Investor optimism is about to be tested |  |
31/01 | Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday |  |
31/01 | Sector Update: Health Care |  |
31/01 | Traders Tread Cautiously as Fed Starts Two-Day Meeting, Fueling Narrow Premarket Losses.. |  |
31/01 | Aktien New York Ausblick: Leicht erholt vor Fed-Zinsentscheid |  |
31/01 | Pfizer : annonce des revenus record mais anticipe des bénéfices 2023 en nette bai.. |  |
31/01 | Pfizer Issues Downbeat Full-Year Outlook With Revenue From COVID-19 Products Set to Tum.. |  |
31/01 | Pfizer: prevede ricavi da vaccini in calo a 13,5 miliardi nel 2023 |  |
31/01 | Pfizer anticipe en 2023 un recul plus important des ventes de ses produits contre le CO.. |  |
31/01 | Pfizer s'attend à une chute des ventes de son vaccin anti-Covid en 2023 |  |
31/01 | Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14, 2018. |  |
31/01 | Pfizer Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 |  |
31/01 | Pfizer Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 |  |
31/01 | Haleon appoints Pfizer Chief Financial Officer David Denton to board |  |
31/01 | Les Bourses troublées par des indicateurs macroéconomiques |  |
31/01 | Pfizer prevé ventas débiles de productos contra el COVID en 2023 |  |
31/01 | Futures drop as earnings roll in, Fed rate decision in focus |  |
31/01 | Pfizer: nel 2022 record, oltre 100 miliardi di dollari |  |
31/01 | Pfizer : hausse de 44% du bénéfice net au 4e trimestre |  |
31/01 | WDH: Pfizer rechnet 2023 mit schleppendem Corona-Geschäft und weniger Gewinn |  |
31/01 | Pfizer's Q4 Adjusted Earnings, Revenue Rise; Fiscal 2023 Outlook Set |  |
31/01 | Pfizer : Q4 Earnings Snapshot |  |
31/01 | GUIDANCE: (PFE) PFIZER Forecasts Fiscal Year 2023 Adjusted EPS Range $3.25 - $3.. |  |
31/01 | Earnings Flash (PFE) PFIZER Posts Q4 Revenue $24.29B, vs. Street Est of $24.40B |  |
31/01 | Earnings Flash (PFE) PFIZER Posts Q4 Adjusted EPS $1.14, vs. Street Est of $1.04 |  |
31/01 | Futures Continue to Trend Down Pre-Bell Ahead of Fed Policy Meeting; Asia, Europe Fall |  |
31/01 | With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Break.. |  |
31/01 | Pfizer : Fourth Quarter 2022 Press Release |  |
31/01 | Pfizer forecasts 2023 sales of COVID products below estimates |  |
31/01 | Pfizer reports record full-year 2022 results and provides full-year 2023 financial guid.. |  |
31/01 | Pfizer Inc. Provides Earnings Guidance for the Financial Year 2023 |  |
31/01 | North American Morning Briefing: Stocks Seen Down -3- |  |
31/01 | North American Morning Briefing: Stocks Seen Down as Rat.. |  |
31/01 | European Midday Briefing: Mood Dampens Ahead of Central Banks |  |
31/01 | USA-Les valeurs à suivre à Wall Street (actualisé) |  |
31/01 | Tech Earnings, Fed Views Damp Wall Street Pre-Bell; Europe Down, Asia Off |  |
31/01 | MARKT USA/Wall Street dürfte mit leichten Abschlägen starten |  |
31/01 | Marketmind: 'Soft landing' or 'no landing'? |  |
31/01 | CAC40 : la prudence domine avant de nombreux résultats |  |
31/01 | Bolsa de Madrid: Un poco de tensión ante la Fed |  |
31/01 | Un peu de tension avant la Fed |  |
31/01 | En Direct des Marchés : Sanofi, Technip Energies, Elis, Seb, EuroA.. |  |
31/01 | CAC 40 : la pause se prolonge malgré de bonnes surprises |  |
31/01 | Dax vor Fed-Entscheid zur Eröffnung niedriger erwartet |  |
31/01 | Marketmind: Mind the gap |  |
31/01 | TAGESVORSCHAU/Dienstag, 31. Januar |  |
31/01 | WOCHENVORSCHAU: Termine bis 13. Februar 2023 |  |
31/01 | PrescriberPoint, Inc. announced that it has received funding from Eli Lilly and Company.. |  |
30/01 | Wall Street termine en berne au début d'une semaine chargée, donc risquée |  |
30/01 | Marketmind: Fasten your seatbelts |  |
30/01 | Recogida de beneficios en Wall Street en una semana decisiva para el mercado |  |
30/01 | Wall Street démarre en baisse une semaine économique très chargée |  |
30/01 | South Africa Expects Delivery of Pediatric Pfizer/BioNTech COVID Vaccine Soon |  |
30/01 | TAGESVORSCHAU/Dienstag, 31. Januar (vorläufige Fassung) |  |
30/01 | Wdh/Aktien New York Ausblick: Schwach - Warten auf Tech-Zah.. |  |
30/01 | Ribon Therapeutics and Pfizer Have Enter into an Agreement |  |
30/01 | Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate |  |
30/01 | Paxlovid sales forecasts may change with Pfizer view on China |  |
30/01 | South Africa Signs Collaboration With Pharmaceutical Association Including GSK, AstraZe.. |  |
30/01 | Ribon Therapeutics, Inc. announced that it has received $25 million in funding from Pfi.. |  |
29/01 | 'WamS': Bislang über 250 Corona-Impfschaden-Anträge genehmigt |  |
27/01 | Health Care Down Ahead of Earnings -- Health Care Roundup |  |
27/01 | S&P 500 Posts 2.5% Weekly Gain Led by Consumer Discretionary, Technology as Q4 GDP, Som.. |  |
27/01 | WOCHENVORSCHAU: Termine bis 10. Februar 2023 |  |
27/01 | Pfizer, BioNTech Reportedly in Talks with EU Over Reducing COVID-19 Vaccine Orders |  |
27/01 | Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases - CDC |  |